Quemliclustat

N/A

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameQuemliclustat
Drug Alias NameAB-680
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-nucleotidase inhibitors
Targets5'-nucleotidase
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[16] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncTaiho Pharmaceutical Co LtdArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A